SurModics to Introduce New Products at MEDICA
9 Nov 2011SurModics In Vitro Technologies, part of SurModics Inc, has announced that it is to showcase two new products at Medica later this month. The SurModics® Assay Diluent (Protein-Free) and BioFX® TMB Enhanced HRP Membrane Substrate, will be on display at the DIARECT/SurModics IVD booth.
The SurModics® Assay Diluent (Protein-Free), is a proprietary protein-free buffer formulation that reduces matrix interference in samples including heterophilic antibodies such as HAMA (human anti-mouse antibody) and RF (rheumatoid factor). The protein-free formulation removes any possible risk of BSA-related issues in sample quantitation. The diluent can be easily incorporated into your assay to provide more accurate results, with fewer false positive results.
BioFX® TMB Enhanced HRP Membrane Substrate has a room temperature stability of 2 years, and 4 year stability at 4°C. The substrate is ready to use with no need for mixing and shows similar sensitivity to most mid- to high-level chemiluminescent membrane substrates, without the costly equipment needed for detection.
You can visit the DIARECT/ SurModics IVD booth in Hall 1 1/E17 at the Medica exhibition in Dusseldorf, Germany, November 16-19, 2011. Alternatively, you can visit them at Booth 849, at the American Society for Cell Biology (ASCB) December 3-7 in Denver.